Autopsy report · NCT00977561
A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer
Cause of deathNo reason given
“See termination reason in detailed description.”
Life of this trial
- Registered 7 months before it started.
- Ran for about 1 year 6 months before it stopped.
- 9 participants enrolled.
- Results were posted on the registry 1 year 4 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Small Cell Lung Carcinoma
- Interventions
- figitumumab; Cisplatin (Or Carboplatin); Etoposide; Cisplatin (Or Carboplatin); Etoposide
- Participants
- 9
- Sites
- 51
- Countries
- Canada, Hungary, Spain, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.